Remove Heart Transplant Remove Pediatrics Remove Ultrasound
article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.

article thumbnail

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Conquering CHD

Zane was diagnosed during a routine ultrasound at 20 weeks’ gestation and his mom, Kayla, was immediately referred to the Colorado Fetal Care Center (CFCC) at Childrens Hospital Colorado. The Heart Institute collaborates with the CFCC through the Fetal Cardiology Program.